Hurley R J, Feldman H S, Latka C, Arthur G R, Covino B G
Department of Anesthesia, Brigham and Women's Hospital, Boston, MA 02115.
Reg Anesth. 1991 Nov-Dec;16(6):303-8.
Ropivacaine is a new local anesthetic that is chemically related to mepivacaine and bupivacaine. Previous laboratory studies have demonstrated that ropivacaine possesses an anesthetic profile similar to that of bupivacaine and has less arrhythmogenic potential. The current study was initiated to compare the hemodynamic and anesthetic effects of epidurally administered 0.75% bupivacaine and 1% ropivacaine, with and without epinephrine (1:200,000), in the dog. Two groups of six dogs were randomly assigned to the ropivacaine or bupivacaine treatment groups. Administration of 0.75% bupivacaine and 1% ropivacaine with and without epinephrine was randomized. Volumes of 3 ml of each solution were injected in a blinded manner via an indwelling lumbar epidural catheter with 48 hours between injections. No statistically significant difference existed between the four treatment groups with regard to onset and duration of sensory or motor block. Hemodynamic changes were, for the most part, not different between drugs. Significant decreases were seen in mean arterial blood pressure and cardiac output in all test groups. No difference in the degree of cardiovascular depression was observed. The addition of epinephrine did not alter onset or duration of sensory or motor block in this animal model. Epinephrine reduced the average anesthetic blood concentration observed in both treatment groups at the various time intervals, but not the time to achieve the mean maximum blood level. No residual adverse effects were observed in any animal.
罗哌卡因是一种新型局麻药,在化学结构上与甲哌卡因和布比卡因相关。以往的实验室研究表明,罗哌卡因具有与布比卡因相似的麻醉特性,且致心律失常的可能性较小。本研究旨在比较硬膜外给予0.75%布比卡因和1%罗哌卡因,加或不加肾上腺素(1:200,000)对犬的血流动力学和麻醉效果。将两组各6只犬随机分为罗哌卡因组或布比卡因组。给予0.75%布比卡因和1%罗哌卡因加或不加肾上腺素的操作是随机的。通过留置的腰段硬膜外导管以盲法注射每种溶液3ml,两次注射间隔48小时。四个治疗组在感觉或运动阻滞的起效时间和持续时间方面无统计学显著差异。药物之间的血流动力学变化在很大程度上无差异。所有试验组的平均动脉血压和心输出量均显著下降。未观察到心血管抑制程度的差异。在该动物模型中,加入肾上腺素并未改变感觉或运动阻滞的起效时间或持续时间。肾上腺素降低了两个治疗组在不同时间间隔观察到的平均麻醉血药浓度,但未改变达到平均最大血药浓度的时间。未在任何动物中观察到残留的不良反应。